Medical Health Encyclopedia

Injury Disease Nutrition Poison Symptoms Surgery Test Special Topic

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Kidney anatomy

Overview Symptoms Treatment Prevention

Membranoproliferative GN II

Alternative Names: Membranoproliferative glomerulonephritis (type II); Glomerulonephritis - membranoproliferative (type II); Mesangiocapillary glomerulonephritis (type II); Dense deposit disease; MPGN II Treatment: Treatment varies according to the symptoms. The goals of treatment are to reduce symptoms, prevent complications, and slow the worsening of the disorder. Text Continues Below Dietary adjustments may include restrictions on sodium, fluids, protein, or other restrictions to control high blood pressure, swelling, and accumulation of waste products in the bloodstream. Antihypertensive medications may be vital to help control blood pressure. Diuretics or other medications may be needed to control swelling or other symptoms. Dialysis or kidney transplantation may eventually be required to manage renal failure. Expectations (prognosis): The disorder progresses slowly to chronic renal failure. Fifty percent of cases will develop chronic renal failure within 10 years. Complications: Acute renal failure Acute nephritic syndrome Nephrotic syndrome Chronic renal failure  Calling your health care provider: Call for an appointment with your health care provider if symptoms indicate MPGN II. Call for an appointment with your health care provider if symptoms worsen or new symptoms develop, including decreased urine output.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2004 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.